MedElevator Войти в исследования
← Поиск публикаций

DOI 10.4084/mjhid.2023.039

Медицинская библиотека · Mediterranean journal of hematology and infectious diseases · 2023

Fludarabine-Based Low-Intensity Conditioning for Fanconi Anemia is Associated with Good Outcomes in Aplastic Anemia but not in MDS - a Single-Center Experience.

Chattopadhyay Sohini, Lionel Sharon, Selvarajan Sushil, Devasia Anup J, Korula Anu, Kulkarni Uday, Na Fouzia, Sindhuvi Eunice, Lakshmi Kavitha M, Srivastava Alok, Abraham Aby, Mathews Vikram, George Biju

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Hematopoietic stem cell transplantation (HSCT) is the only curative option for patients with Fanconi Anemia (FA) with hematological abnormalities.

MATERIALS AND

METHODS

This is a retrospective analysis of patients with FA who underwent a matched-related donor HSCT.

RESULTS

Sixty patients underwent 65 transplants between 1999-2021 using a fludarabine-based low-intensity conditioning regimen. The median age at transplant was 11 years (range: 3-37). Aplastic anemia (AA) was the underlying diagnosis in 55 (84.6%), while 8 (12.4%) had myelodysplastic syndrome (MDS) and 2 (3%) had acute myeloid leukemia (AML). The conditioning regimen used was Fludarabine with low-dose Cyclophosphamide for aplastic anemia and Fludarabine with low-dose Busulfan for MDS/AML. Graft versus host disease (GVHD) prophylaxis consisted of Cyclosporine and methotrexate. Peripheral blood was the predominant stem cell graft source (86.2%). Engraftment occurred in all but one patient. The median time to neutrophil and platelet engraftment was 13 days (range: 9-29) & 13 days (range: 5-31), respectively. Day 28 chimerism analysis showed complete chimerism in 75.4 % and mixed chimerism in 18.5%. Secondary graft failure was encountered in 7.7%. Grade II-IV acute GVHD occurred in 29.2%, while Grade III-IV acute GVHD occurred in 9.2%. Chronic GVHD was seen in 58.5% and was limited in most patients. The median follow-up is 55 months (range: 2-144) & the 5-year estimated overall survival (OS) is 80.2 ± 5.1%. Secondary malignancies were noted in 4 patients. The 5-year OS was significantly higher in patients undergoing HSCT for AA (86.6 + 4.7%) as compared to MDS/AML (45.7+16.6%) (p= 0.001).

CONCLUSION

SCT using a fully matched donor provides good outcomes with low-intensity conditioning regimens in patients with FA who have aplastic marrow.

Для цитирования: Chattopadhyay Sohini, Lionel Sharon, Selvarajan Sushil, Devasia Anup J, Korula Anu, Kulkarni Uday, Na Fouzia, Sindhuvi Eunice, Lakshmi Kavitha M, Srivastava Alok, Abraham Aby, Mathews Vikram, George Biju. Fludarabine-Based Low-Intensity Conditioning for Fanconi Anemia is Associated with Good Outcomes in Aplastic Anemia but not in MDS - a Single-Center Experience.. Mediterranean journal of hematology and infectious diseases. 2023. DOI: 10.4084/mjhid.2023.039.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.